title: Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
abstract: Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.
authors.affiliation: Department of Gynecology and Obstetrics, Georg-August-University, Göttingen, Germany. boriana_jahns@yahoo.com
authors.forename: Boriana G
authors.initials: BG
authors.lastname: Jahns
authors.forename: Werner
authors.initials: W
authors.lastname: Stein
authors.forename: Denise
authors.initials: D
authors.lastname: Hilfiker-Kleiner
authors.forename: Burkert
authors.initials: B
authors.lastname: Pieske
authors.forename: Günter
authors.initials: G
authors.lastname: Emons
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000188:drug therapy* / Q000378:metabolism; D002402:Cathepsin D / Q000378:metabolism; D005260:Female; D017359:HELLP Syndrome; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006727:Hormone Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy* / Q000378:metabolism; D011388:Prolactin / Q000037:antagonists & inhibitors
chemical_list: D006727:Hormone Antagonists; D001971:Bromocriptine; D011388:Prolactin; D002402:Cathepsin D